Bank of America
NXTC icon

Bank of America’s NextCure NXTC Stock Holding History

Bank of America’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-173
Closed -$2.45K – 6524
2025
Q4 		$2.45K Buy
173
+150
+652% +$1.55K ﹤0.01% 6383
2025
Q3 		$134 Hold
23
– – ﹤0.01% 7796
2025
Q2 		$125 Buy
23
+1
+5% +$5 ﹤0.01% 7932
2025
Q1 		$126 Buy
22
+1
+5% +$9 ﹤0.01% 7786
2024
Q4 		$194 Sell
21
-428
-95% -$6.29K ﹤0.01% 7592
2024
Q3 		$7.38K Buy
449
+2
+0.4% +$37 ﹤0.01% 6947
2024
Q2 		$8.54K Buy
447
+220
+97% +$4.28K ﹤0.01% 6918
2024
Q1 		$6.08K Buy
227
+225
+11,250% +$3.88K ﹤0.01% 6969
2023
Q4 		$29 Buy
+2
New +$29 ﹤0.01% 7593
2023
Q3 		– Hold
0
– – – 7715
2023
Q2 		– Hold
0
– -$3 – 7867
2023
Q1 		– Sell
-4
Closed -$77 – 7703
2022
Q4 		$68 Sell
4
-311
-99% -$7.15K ﹤0.01% 7743
2022
Q3 		$10K Sell
315
-3,005
-91% -$153K ﹤0.01% 7240
2022
Q2 		$187K Buy
3,320
+1,874
+130% +$97.9K ﹤0.01% 6142
2022
Q1 		$85K Sell
1,446
-430
-23% -$26.9K ﹤0.01% 6942
2021
Q4 		$135K Buy
1,876
+59
+3% +$4.94K ﹤0.01% 6719
2021
Q3 		$147K Sell
1,817
-1,511
-45% -$132K ﹤0.01% 6502
2021
Q2 		$321K Sell
3,328
-1,011
-23% -$103K ﹤0.01% 5756
2021
Q1 		$522K Buy
4,339
+258
+6% +$37.4K ﹤0.01% 5323
2020
Q4 		$533K Buy
4,081
+3,325
+440% +$430K ﹤0.01% 4971
2020
Q3 		$80K Sell
756
-3,158
-81% -$388K ﹤0.01% 5796
2020
Q2 		$1.01M Sell
3,914
-7,629
-66% -$2.9M ﹤0.01% 4112
2020
Q1 		$5.13M Buy
11,543
+5,998
+108% +$3.2M ﹤0.01% 2646
2019
Q4 		$3.75M Buy
5,545
+4,667
+532% +$2.34M ﹤0.01% 3504
2019
Q3 		$325K Buy
878
+814
+1,272% +$265K ﹤0.01% 5365
2019
Q2 		$11K Buy
+64
New +$13.3K ﹤0.01% 6707

Other funds holding NXTC

SCM
Squadron Capital Management Westmont, Illinois $273M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Bank of America's NXTC Position: Q1 2026 in Review

Bank of America sold out of NextCure (NXTC) in Q1 2026, closing a stake of 173 shares — an estimated $2.45K sold.

Bank of America first reported a position in NXTC in Q2 2019 and held it in 24 quarters. The position peaked at $5.13M in Q1 2020. 26 funds tracked by Wall St. Rank hold NXTC as of Q1 2026.

  • Bank of America reported no remaining NextCure position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 173 NextCure shares in Q1 2026, an estimated $2.45K.
  • Bank of America first reported a position in NextCure in Q2 2019 and held it in 24 quarters.
  • Bank of America's NextCure position peaked at $5.13M in Q1 2020.
  • 26 funds tracked by Wall St. Rank held NextCure as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.